Todd D. Schell

Tumor-Specific T Cell Dysfunction Is a Dynamic Antigen-Driven Differentiation Program Initiated Early during Tumorigenesis

Andrea Schietinger, Mary Philip, Varintra E. Krisnawan et al. · Immunity · 2016 · 699 citations · Full text

Tumor Immunology, Cancer Immunosurveillance, T-regulatory Cell +10

T-Cell Immunoglobulin and ITIM Domain (TIGIT) Associates with CD8+ T-Cell Exhaustion and Poor Clinical Outcome in AML Patients

Yaxian Kong, Liuluan Zhu, Todd D. Schell et al. · Clinical Cancer Research · 2016 · 288 citations

Beta blocker use correlates with better overall survival in metastatic melanoma patients and improves the efficacy of immunotherapies in mice

Kathleen M. Kokolus, Ying Zhang, Jeffrey Sivik et al. · OncoImmunology · 2017 · 168 citations · Full text

Improved survival and complete response rates in patients with advanced melanoma treated with concurrent ipilimumab and radiotherapy versus ipilimumab alone

Kristian Michael Koller, Heath B. Mackley, Jason Liu et al. · Cancer Biology & Therapy · 2016 · 154 citations · Full text

Surgical Oncology, Oncology, Radiation Therapy +13

Nanoliposome C6-Ceramide Increases the Anti-tumor Immune Response and Slows Growth of Liver Tumors in Mice

Guangfu Li, Dai Liu, Eric T. Kimchi et al. · Gastroenterology · 2018 · 143 citations · Full text